Award
Delivery Order #75N91026F00033
Study of Bundibugyo Virus Natural History by Leidos Biomedical
Buyer
National Institutes of Health
Award Amount
$11,725,031.00
Ceiling
$11,725,031.00
Awarded
September 25, 2026
Period of Performance
Sep 25, 2026 – Sep 24, 2029
Identifier
75N91026F00033
NAICS
541715
This award is a delivery order contract placed under a larger Federally Funded Research and Development Center (FFRDC) contract, signifying a specialized, task-specific extension of the existing agreement. The contract has been awarded to Leidos Biomedical Research, Inc., a subsidiary of Leidos Holdings, Inc., recognized for its expertise in biomedical research supporting public health initiatives. The contract involves conducting an observational study to understand the natural history of Bundibugyo virus disease, contributing valuable epidemiological data and advancing infectious disease knowledge. The significance of this contract lies in its role in enhancing biodefense and public health preparedness against emerging viral threats. The scope includes detailed observational research activities in Frederick, Maryland, aiming to collect and analyze natural progression data on the virus. The award was likely made under a competitive process, given its foundation in a significant ongoing FFRDC contract supporting the National Cancer Institute (NCI). Key milestones span a multi-year timeframe from late 2026 through late 2029, allowing comprehensive data gathering and analysis. This delivery order leverages the broad capabilities of Leidos within a structured contract vehicle focused on critical biomedical research.
Description
PALM004: AN OBSERVATIONAL STUDY OF THE NATURAL HISTORY OF BUNDIBUGYO VIRUS DISEASE